标题
Clinical pharmacology of intravitreal anti-VEGF drugs
作者
关键词
-
出版物
EYE
Volume 32, Issue 6, Pages 1010-1020
出版商
Springer Nature
发表日期
2018-01-31
DOI
10.1038/s41433-018-0021-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Differential hypoxic response of human choroidal and retinal endothelial cells proposes tissue heterogeneity of ocular angiogenesis
- (2016) P. Mammadzada et al. ACTA OPHTHALMOLOGICA
- Receiver Operating Characteristic Curve to Predict Anti-VEGF Resistance in Retinal Vein Occlusions and Efficacy of Ozurdex
- (2016) Jeremy D. Wolfe et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- Response to anti-VEGF-A treatment of endothelial cells in vitro
- (2016) Alessandra Puddu et al. EXPERIMENTAL EYE RESEARCH
- Risk of geographic atrophy in age-related macular degeneration patients treated with intravitreal anti-VEGF agents
- (2016) M Gemenetzi et al. EYE
- Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
- (2016) John A. Wells et al. OPHTHALMOLOGY
- Pathophysiology and pharmacological targets of VEGF in diabetic macular edema
- (2016) Stefano Fogli et al. PHARMACOLOGICAL RESEARCH
- Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema
- (2016) Jeffrey S. Heier et al. JAMA Ophthalmology
- Inhibition of Ocular Neovascularization by Co-Inhibition of VEGF-A and PLGF
- (2015) Xiaochuan Huo et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Aflibercept: A Review in Metastatic Colorectal Cancer
- (2015) Yahiya Y. Syed et al. DRUGS
- Intraocular pharmacokinetics of intravitreal vascular endothelial growth factor-Trap in a rabbit model
- (2015) S J Park et al. EYE
- Residual edema evaluation with ranibizumab 0.5 mg and 2.0 mg formulations for diabetic macular edema (REEF study)
- (2015) D S Dhoot et al. EYE
- Defining response to anti-VEGF therapies in neovascular AMD
- (2015) W M Amoaku et al. EYE
- Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Molecular pathogenesis of retinal and choroidal vascular diseases
- (2015) Peter A. Campochiaro PROGRESS IN RETINAL AND EYE RESEARCH
- Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: A review
- (2015) Megan Kim et al. SURVEY OF OPHTHALMOLOGY
- Comparison of Eylea® with Lucentis® as first-line therapy in patients with treatment-naïve neovascular age-related macular degeneration in real-life clinical practice: retrospective case-series analysis
- (2015) Sophie C. Böhni et al. BMC Ophthalmology
- Serum and Plasma Vascular Endothelial Growth Factor Concentrations Before and After Intravitreal Injection of Aflibercept or Ranibizumab for Age-Related Macular Degeneration
- (2014) Xiying Wang et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD
- (2014) Robert L Avery et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Efficacy and adverse events of aflibercept, ranibizumab and bevacizumab in age-related macular degeneration: a trade-off analysis
- (2014) Martin K Schmid et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Switch of anti-VEGF agents is an option for nonresponders in the treatment of AMD
- (2014) C Ehlken et al. EYE
- Effect of Switching Therapy to Pegaptanib in Eyes With the Persistent Cases of Exudative Age-Related Macular Degeneration
- (2014) Chieko Shiragami et al. MEDICINE
- Comparison of Binding Characteristics and In Vitro Activities of Three Inhibitors of Vascular Endothelial Growth Factor A
- (2014) Jihong Yang et al. MOLECULAR PHARMACEUTICS
- Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration
- (2014) Allen C. Ho et al. OPHTHALMOLOGY
- Intravitreal Aflibercept for Diabetic Macular Edema
- (2014) Jean-François Korobelnik et al. OPHTHALMOLOGY
- Anti-VEGF Agents with or without Antimetabolites in Trabeculectomy for Glaucoma: A Meta-Analysis
- (2014) Qi Xiong et al. PLoS One
- Human Ciliary Epithelium as a Source of Synthesis and Secretion of Vascular Endothelial Growth Factor in Neovascular Glaucoma
- (2014) Kakarla V. Chalam et al. JAMA Ophthalmology
- Non-responders to treatment with antagonists of vascular endothelial growth factor in age-related macular degeneration
- (2013) Ilse Krebs et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab, ranibizumab and pegaptanib in patients with age-related macular degeneration, and in patients with diabetic macular oedema
- (2013) Claus Zehetner et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Efficacy of intravitreal bevacizumab after unresponsive treatment with intravitreal ranibizumab
- (2013) Arghavan Almony et al. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE
- Common Variant in VEGFA and Response to Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration
- (2013) L. Zhao et al. CURRENT MOLECULAR MEDICINE
- VEGF but not PlGF disturbs the barrier of retinal endothelial cells
- (2013) Heidrun L. Deissler et al. EXPERIMENTAL EYE RESEARCH
- Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial
- (2013) Usha Chakravarthy et al. LANCET
- VISUAL AND ANATOMICAL OUTCOMES OF INTRAVITREAL AFLIBERCEPT IN EYES WITH PERSISTENT SUBFOVEAL FLUID DESPITE PREVIOUS TREATMENTS WITH RANIBIZUMAB IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2013) Nishant Kumar et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Antiangiogenic Therapy for Ischemic Retinopathies
- (2013) M. Al-Latayfeh et al. Cold Spring Harbor Perspectives in Medicine
- PlGF: A Multitasking Cytokine with Disease-Restricted Activity
- (2013) M. Dewerchin et al. Cold Spring Harbor Perspectives in Medicine
- Intraocular Pharmacokinetics of Ranibizumab Following a Single Intravitreal Injection in Humans
- (2012) Tim U. Krohne et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
- (2012) Nicholas Papadopoulos et al. ANGIOGENESIS
- Characterization of the long-term pharmacokinetics of bevacizumab following last dose in patients with resected stage II and III carcinoma of the colon
- (2012) Jing Li et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Impact of Low Levels of Vascular Endothelial Growth Factor After Myocardial Infarction on 6-Month Clinical Outcome
- (2012) Kyoko Matsudaira et al. CIRCULATION JOURNAL
- Anterior segment uses of bevacizumab
- (2012) Irit Bahar et al. CURRENT OPINION IN OPHTHALMOLOGY
- Ocular Hypertension Following Intravitreal Anti-vascular Endothelial Growth Factor Agents
- (2012) Ravi S. J. Singh et al. DRUGS & AGING
- Targeted deletion of Vegfa in adult mice induces vision loss
- (2012) Toshihide Kurihara et al. JOURNAL OF CLINICAL INVESTIGATION
- Aflibercept
- (2012) Michael W. Stewart et al. NATURE REVIEWS DRUG DISCOVERY
- Ranibizumab for Macular Edema Due to Retinal Vein Occlusions
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
- Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
- (2012) Daniel F. Martin et al. OPHTHALMOLOGY
- Ranibizumab for Diabetic Macular Edema
- (2012) Quan Dong Nguyen et al. OPHTHALMOLOGY
- Corneal Neovascularization: An Anti-VEGF Therapy Review
- (2012) Jin-Hong Chang et al. SURVEY OF OPHTHALMOLOGY
- Comparing protein VEGF inhibitors: In vitro biological studies
- (2011) Lanlan Yu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Tachyphylaxis during treatment of exudative age-related macular degeneration with ranibizumab
- (2011) Maria Salling Eghøj et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Congestive Heart Failure Risk in Patients With Breast Cancer Treated With Bevacizumab
- (2011) Toni K. Choueiri et al. JOURNAL OF CLINICAL ONCOLOGY
- Population Pharmacokinetics of Pegaptanib in Patients With Neovascular, Age-Related Macular Degeneration
- (2011) Anthony S. Basile et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Bevacizumab versus Ranibizumab for AMD
- (2011) Philip J. Rosenfeld NEW ENGLAND JOURNAL OF MEDICINE
- Sustained Benefits from Ranibizumab for Macular Edema Following Branch Retinal Vein Occlusion: 12-Month Outcomes of a Phase III Study
- (2011) David M. Brown et al. OPHTHALMOLOGY
- Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III Study
- (2011) Peter A. Campochiaro et al. OPHTHALMOLOGY
- Angiogenesis
- (2011) D. R. Senger et al. Cold Spring Harbor Perspectives in Biology
- Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies
- (2010) Ron J. Keizer et al. CLINICAL PHARMACOKINETICS
- Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study): A 12-month, randomized, controlled, double-masked, multicenter phase II study
- (2010) P. Massin et al. DIABETES CARE
- Impact of soluble fms-like tyrosine kinase-1 and placental growth factor serum levels for risk stratification and early diagnosis in patients with suspected acute myocardial infarction
- (2010) W. Hochholzer et al. EUROPEAN HEART JOURNAL
- Activated VEGF Receptor Shed Into the Vitreous in Eyes With Wet AMD
- (2009) Geetanjali Davuluri ARCHIVES OF OPHTHALMOLOGY
- Renal FcRn Reclaims Albumin but Facilitates Elimination of IgG
- (2009) M. Sarav et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
- (2009) Quan Dong Nguyen et al. OPHTHALMOLOGY
- An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris
- (2009) M. Saint-Geniez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- COMPARISON OF INTRAVITREAL BEVACIZUMAB FOLLOWED BY RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2009) KIMBERLY E. STEPIEN et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- TACHYPHYLAXIS AFTER INTRAVITREAL BEVACIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
- (2009) FARZIN FOROOGHIAN et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started